Translational Chemical Biology: Hunt for Next Generation Chemical Probes/Drug Candidates in the Cancer Cell Signaling Arena.

Size: px
Start display at page:

Download "Translational Chemical Biology: Hunt for Next Generation Chemical Probes/Drug Candidates in the Cancer Cell Signaling Arena."

Transcription

1 Translational Chemical Biology: unt for Next Generation Chemical Probes/Drug Candidates in the Cancer Cell Signaling Arena Prabhat Arya 1

2 small molecule binder From enzymes /isolated protein targets Rethinking Drug Discovery Pharma Focus Asia, Nov 2014 Well defined Compact Deep pocket Protein complexes/ signaling pathways 2

3 Map large surface area Shallow surface Combination of several weak interactions Extended hydrophobic interactions Possible hot spots May 14, 2014 Issue Theme: Chemical Biology of Protein-Protein Interactions 3

4 Natural Products as Modulators of PPIs Me Me Me Me N Me FK506 Me Me Me 2 N Eribulin Complex 3D architectures! Dense display of stereo-defined groups 4

5 Growing Faith in the Emerging Chemical Biology Model Modern rganic Synthesis Novel Chemical Toolbox Biologically Relevant Chemical Space Natural Product-like Natural Product-inspired ybrid Natural Products Cell Signaling Biology (Biological Questions/ Novel Assays) Cellular Assays Zebrafish Assays ther rganisms Biophysics and Structural Biology SPR Protein NMR Computational Tools 5

6 Exploring Biologically Relevant Chemical Space Bioactive Natural Products Building Macrocyclic Diversity-based Chemical Toolbox Natural Product- Inspired Substructures Natural product-like 3D architectures Sufficient complexity with a few chiral functional groups Incorporation of stereochemical and skeletal diversity Synthesis in a reasonable time-scale Easy to carry-out follow-up medicinal chemistry studies From Arya Research Team: Chem. & Biol. 145 (2002) and 163 (2005) Curr. pin. Chem. Biol. 247 (2005) Chem. Rev (2009)

7 Large 3D surface area Numerous binding interactions Excellent track record in finding bioactives Functionalized pre-organized dynamic Shapes Rich in chiral display of functional groups Nat. Rev. Drug Disc. 2008, 7,

8 Building A Chemical Toolbox Me Rapamycin N S Latrunculol A N Me Me 2 N Eribulin Epothilone/Ixabepilone 8

9 Latrunculins as Actin Modulators Isolated from Red Sea sponge Negombata magnifica Potent G-actin Inhibitors Latrunculol A is more potent compared to other family members J. Med. Chem. 2008, 51,

10 Latrunculin-derived ybrid Macrocycles Diversity site R 1 N R1 N Me Me PMBN PMBN Madhu Aeluri S S 10

11 Synthesis of ybrid Macrocycles TBDPS Me PMBN S i. Na, allyl bromide DMF,RT,5h ii.tbaf,tf,rt,1h 70%for2steps ~10.0 gms scale Me PMBN S R N EDCI, DMAP, DCM RT,4h,85-90% R N R N Me PMBN S i.g-ii(10mol%) DCM,reflux,3h ii. 2,10%Pd/C Et,RT,12h 60%for2steps Me PMBN S R=i-Pr R=Bn R=i-Bu R=s-Bu R=Me Aeluri, Dasari, Arya, rg. Lett ASAP 11

12 Eribulin as A Tubulin Binder FDA approved anticancer drug (Nov, 2010) marketed by Esai Synthetic analog of a marine sponge natural product, alichondrin B Mechanistically, a unique inhibitor of microtubule dynamics 12

13 ur 1 st Generation ybrid Macrocycles Eribulin Macrocycle N R Jimmidi, Krishna Reddy, Arya rg. Lett ASAP Ravi Kumar Jimmidi 13

14 ybrid Rapamycins Nat Rev Cancer 2006 Me N Me Me Nat Rev Neuroscience

15 ur 1 st Generation Plan Shiva Krishna Reddy Guduru Me N Me 16 Me Practical and scalable synthesis 22-membered macrocyclic ring Imbedded Amino alcohol moiety as the diversity site N 1 R 2 16 N 18 R 1 Krishna Reddy Guduru, Jimmidi, Deora, Arya rg. Lett ASAP 15

16 Collaborative Study: Probing Cancer Stem Cells by Small Molecules Dr. Satish Kitambi Dept of Medical Biochem and Biophysics, Karolinska Institutet Dr. Subhadra Dravida Tran-Scell Biologics yderabad Dr. Kiranam Chatti DRILS yderabad (Zebrafish / Cytoskeleton Signaling) Dr. Prasenjit Mitra DRILS yderabad (Mitochondria Signaling) 16

17 Nat. Rev. Drug Discovery July

18 Nat. Rev. Drug Discovery July

19 ur Collaborative Roadmap Isolation of Cancer Stem Cells (CSCs) from human brain tumor. Validation of Cancer Stem Cells. Identification of small molecules as highly selective killers of CSCs. Understanding of specific pathways affected by small molecule hits! Cell survival assays using CSCs vs cancer cells. Cell survival, proliferation and migration assays with CSCs in zebrafish. 19

20 Cell 2009 Salinomycin C 20

21 Cell 2014 Kitambi Karolinska 21

22 Cell Viability Assay (Cancer Stem Cells Derived from uman Brain Tumor Cells) Inte ensity (a. u) ATP measurement! Me Me N N N NMe from our toolbox Apoptosis inducer (by Caspase 3 activation) Compounds Kitambi Karolinska 22

23 Cancer Stem Cells: Proliferation and Cell Migration in Zebrafish Model! Lateral view of 2 days old zebrafish larvae with DAPI (stains all the nucleus as blue) and the newly transplanted CSC in red Dorsal view of approximately 1 month old zebrafish transplanted with CSCs labelled red brain brain eye Cancer Stem Cells Kitambi Karolinska 23

24 Sincere Thanks to Arya Academic Research Team in Canada (past) and India (2009- present) NRC Canada Genomics and ealth Initiative Science and Technology Park University of Pune Chemical Biology McGill University Chemical Biology Program Broad Institute of arvard and MIT

Recent years have witnessed an expansion in the disciplines encompassing drug

Recent years have witnessed an expansion in the disciplines encompassing drug Course overview Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of Universities

More information

FRAUNHOFER IME SCREENINGPORT

FRAUNHOFER IME SCREENINGPORT FRAUNHOFER IME SCREENINGPORT Detection technologies used in drug discovery Introduction Detection technologies in drug discovery is unlimited only a biased snapshot can be presented Differences can presented

More information

Druggability & DruGUI. Ahmet Bakan Department of Computational and Systems Biology

Druggability & DruGUI. Ahmet Bakan Department of Computational and Systems Biology Druggability & DruGUI Ahmet Bakan ahb12@pitt.edu Department of Computational and Systems Biology Target Druggability Can a given biological target, such as a protein, bind with high affinity to a drug?

More information

EOS: a Focussed Oncology Company Overview Forum della Ricerca e dell Innovazione Padova, May 16, 2008

EOS: a Focussed Oncology Company Overview Forum della Ricerca e dell Innovazione Padova, May 16, 2008 Growing and Nurturing Right Ideas EOS: a Focussed Oncology Company Overview Forum della Ricerca e dell Innovazione Padova, May 16, 2008 EOS S.p.A. (Ethical Oncology Science) Via Monte di Pietà 1/A, Milan,

More information

Drug Discovery Targeting the GHKL Superfamily - HSP90, DNA Gyrase, Histidine Kinases

Drug Discovery Targeting the GHKL Superfamily - HSP90, DNA Gyrase, Histidine Kinases Drug Discovery Targeting the GHKL Superfamily - HSP90, DNA Gyrase, Histidine Kinases (Jason) Xinshan Kang, Boris Klebansky, Richard Fine BioPredict, Inc., 660 KinderKamack Rd., radell, NJ 07649 232 nd

More information

Introduction to Assay Development

Introduction to Assay Development Introduction to Assay Development A poorly designed assay can derail a drug discovery program before it gets off the ground. While traditional bench-top assays are suitable for basic research and target

More information

Advancing Life Sciences

Advancing Life Sciences Advancing Life Sciences Sweden s largest center for life sciences A national resource SciLifeLab, Science for Life Laboratory, is a Swedish national center for molecular biosciences, with the mission to

More information

Call for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas

Call for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas Call for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas Applications due: Oct 3 rd, 2016 Anticipated Decision Date:

More information

Design, docking study and ADME prediction of Chalcone derivatives as potent Tubulin inhibitors

Design, docking study and ADME prediction of Chalcone derivatives as potent Tubulin inhibitors Journal of Computational Methods in Molecular Design, 2014, 4 (1):1-5 Scholars Research Library (http://scholarsresearchlibrary.com/archive.html) ISSN : 2231-3176 CODEN (USA): JCMMDA Design, docking study

More information

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing Overview Serving biotech and pharma community since 1998 Proven track record of advancing small molecules from

More information

The Integrated Biomedical Sciences Graduate Program

The Integrated Biomedical Sciences Graduate Program The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to

More information

TARGET VALIDATION. Maaike Everts, PhD (with slides from Dr. Suto)

TARGET VALIDATION. Maaike Everts, PhD (with slides from Dr. Suto) TARGET VALIDATION Maaike Everts, PhD (with slides from Dr. Suto) Drug Discovery & Development Source: http://dlab.cl/molecular-design/drug-discovery-phases/ How do you identify a target? Target: the naturally

More information

Case Studies ZoBio

Case Studies ZoBio Case Studies 2011 ZoBio ZoBio Corporate Overview Founded as Dutch BV 11/2004 Full access to all lab facilities of UL Self funded (grants and commercial activities) Doubled income 5 consecutive years 9

More information

University of Pennsylvania Perelman School of Medicine High Throughput Screening Core

University of Pennsylvania Perelman School of Medicine High Throughput Screening Core University of Pennsylvania Perelman School of Medicine High Throughput Screening Core Sara Cherry, Ph. D. David C. Schultz, Ph. D. dschultz@mail.med.upenn.edu (215) 573 9641 67 John Morgan Building Mission

More information

Innovative Medicines Initiative

Innovative Medicines Initiative Innovative Medicines Initiative EMA - EBE Regulatory Conference on ATMPs Salah-Dine Chibout, Novartis Global Head Discovery & Investigative Safety/ Global Head Preclinical Safety Therapeutic Areas IMI

More information

Recent Progress of Interprotein s Research Activities. Interprotein Corporation

Recent Progress of Interprotein s Research Activities. Interprotein Corporation Recent Progress of Interprotein s Research Activities - INTENDD and AI-guided INTENDD - Interprotein Corporation 1 Interprotein Corporation Location: Osaka, Japan Year Established: 2001 CEO & President:

More information

Biomolecular Characterization for Rational Drug Design. Maria João Romão

Biomolecular Characterization for Rational Drug Design. Maria João Romão Biomolecular Characterization for Rational Drug Design Maria João Romão UCIBIO@REQUIMTE Applied Molecular Biosciences Unit Chemistry Department - FCT NOVA mjr@fct.unl.pt / http://sites.fct.unl.pt/xtal

More information

Allosteric inhibitors of the NS3 protease from the hepatitis C virus with a new action mechanism

Allosteric inhibitors of the NS3 protease from the hepatitis C virus with a new action mechanism Jornada 2-2012: Zaragoza Allosteric inhibitors of the NS3 protease from the hepatitis C virus with a new action mechanism Zaragoza, 6 de junio de 2012 Content 1. The Research Group 2. The Product a) Target

More information

Centre for Drug Design and Discovery CD3. Centre for Drug Design and Discovery

Centre for Drug Design and Discovery CD3. Centre for Drug Design and Discovery Centre for Drug Design and Discovery 3 Centre for Drug Design and Discovery The investment fund for innovative small molecule academic drug discovery" 16 June 2010 UCL - Sopartec 3? THE CENTRE FOR DRUG

More information

Genomics Research Center: Current Status & Future Development

Genomics Research Center: Current Status & Future Development Genomics Research Center: Current Status & Future Development Introduction Research in the life sciences has entered a new era after completion of the human genome project and the sequencing of the genomes

More information

COMPUTER AIDED DRUG DESIGN: AN OVERVIEW

COMPUTER AIDED DRUG DESIGN: AN OVERVIEW Available online on 19.09.2018 at http://jddtonline.info Journal of Drug Delivery and Therapeutics Open Access to Pharmaceutical and Medical Research 2011-18, publisher and licensee JDDT, This is an Open

More information

Proteomics. Manickam Sugumaran. Department of Biology University of Massachusetts Boston, MA 02125

Proteomics. Manickam Sugumaran. Department of Biology University of Massachusetts Boston, MA 02125 Proteomics Manickam Sugumaran Department of Biology University of Massachusetts Boston, MA 02125 Genomic studies produced more than 75,000 potential gene sequence targets. (The number may be even higher

More information

Docking Studies of the Binding Mode of Dictyostatin and Its Analogues to the Taxoid Binding Site on Tubulin

Docking Studies of the Binding Mode of Dictyostatin and Its Analogues to the Taxoid Binding Site on Tubulin Docking Studies of the Binding Mode of Dictyostatin and Its Analogues to the Taxoid Binding Site on Tubulin Christopher B. Hackmeyer Spring Hill College Billy W. Day, Ph.D. Department of Pharmaceutical

More information

Real World Drug Discovery A Chemist's Guide to Biotech and Pharmaceutical Research

Real World Drug Discovery A Chemist's Guide to Biotech and Pharmaceutical Research Real World Drug Discovery A Chemist's Guide to Biotech and Pharmaceutical Research Robert M. Rydzewski ELSEVIER Amsterdam Boston Heidelberg London New York Oxford Paris San Diego San Francisco Singapore

More information

Fragment-based screening of enzyme drug targets: Microfluidic mobility shift assay improves confidence in candidate selection

Fragment-based screening of enzyme drug targets: Microfluidic mobility shift assay improves confidence in candidate selection Fragment-based screening of enzyme drug targets: Microfluidic mobility shift assay improves confidence in candidate selection Introduction Fragment-based lead discovery is establishing itself as valuable

More information

DHODH: StructureGuided Design of a. New Class of Drugs. Defeating Malaria Together. Meg Phillips, Ph.D. UT Southwestern

DHODH: StructureGuided Design of a. New Class of Drugs. Defeating Malaria Together. Meg Phillips, Ph.D. UT Southwestern DHODH: StructureGuided Design of a New Class of Drugs Defeating Malaria Together Meg Phillips, Ph.D. UT Southwestern 1 Pipeline to development of a DHODH-based anti-malarial 2001 Phillips enzymology/ structure/hts;

More information

KNIME as a Platform for Integrated Hit Finding at Novartis. Patrick S. Lee Ph.D. KNIME Fall Summit 2016 San Francisco 9/16/2016

KNIME as a Platform for Integrated Hit Finding at Novartis. Patrick S. Lee Ph.D. KNIME Fall Summit 2016 San Francisco 9/16/2016 KIME as a Platform for Integrated Hit Finding at ovartis Patrick S. Lee Ph.D. KIME Fall Summit 2016 San Francisco 9/16/2016 Agenda Overview of ovartis Hit finding in drug discovery KIME integration 2 A

More information

Dr Amy Prosser Careers in Research: Industry

Dr Amy Prosser Careers in Research: Industry www.rsb.org.uk Dr Amy Prosser Careers in Research: Industry @RoyalSocBio #BiologyWeek #RSBcareersDay Careers in Research: Working in the Pharma Industry Dr Amy Prosser My Career History 2011 Completed

More information

MANIFESTO OF STUDIES 2012

MANIFESTO OF STUDIES 2012 MANIFESTO OF STUDIES 2012 1st YEAR Course Teacher Hours Synopsis Evaluation procedure Laboratory Safety Course (Mandatory) Prof. Mancini I. Dr. Provenzani A. 12 General Laboratory Procedures, Equipment

More information

A Review on Microdosing: Reduction in Cost & Time

A Review on Microdosing: Reduction in Cost & Time Human Journals Review Article June 2016 Vol.:6, Issue:3 All rights are reserved by Rupali Yevale et al. A Review on Microdosing: Reduction in Cost & Time Keywords: Microdosing, phase 0, LC-MS and AMS ABSTRACT

More information

Program overview. SciLifeLab - a short introduction. Advanced Light Microscopy. Affinity Proteomics. Bioinformatics.

Program overview. SciLifeLab - a short introduction. Advanced Light Microscopy. Affinity Proteomics. Bioinformatics. Open House Program SciLifeLab Open House in Stockholm November 4, 2015 09:00-16:00 Contact: events@scilifelab.se Program overview 09:00-09:30-10:00-10:30-11:00-11:30-12:00-12:30-13:00-13:30-14:00-14:30-15:00-15:30-09:30

More information

Pharmaceutical Informatics and the Pathway to Personalized Medicines

Pharmaceutical Informatics and the Pathway to Personalized Medicines Pharmaceutical Informatics and the Pathway to Personalized Medicines Sangtae Kim and Venkat Venkatasubramanian Purdue University ICCS2007 DDDAS Workshop Beijing May 26-28, 2007 Outline The Grand Challenge

More information

BIOL 461/ 661 Cell Biology 4 Credits Instructor: Dr. Kristin O Brien. T/TH 11:30-1:00, Irving I 208 Office hours: M 9-10, TH 3-4

BIOL 461/ 661 Cell Biology 4 Credits Instructor: Dr. Kristin O Brien. T/TH 11:30-1:00, Irving I 208 Office hours: M 9-10, TH 3-4 BIOL 461/ 661 Cell Biology 4 Credits Instructor: Dr. Kristin O Brien Prerequisites: BIOL 362 Principals of Genetics Office: 226 Arctic Health CHEM 321 Organic Chemistry Laboratory: 229 Arctic Health T/TH

More information

The Major Function Of Rna Is To Carry Out The Genetic Instructions For Protein Synthesis

The Major Function Of Rna Is To Carry Out The Genetic Instructions For Protein Synthesis The Major Function Of Rna Is To Carry Out The Genetic Instructions For Protein Synthesis For example, protein synthesis in human mitochondria relies on a genetic code that Leder and Nirenberg were able

More information

Hitting the target in phenotypic drug discovery: Advances in receptor deconvolution

Hitting the target in phenotypic drug discovery: Advances in receptor deconvolution Hitting the target in phenotypic drug discovery: Advances in receptor deconvolution Jim Freeth, Retrogenix, UK Jim.Freeth@retrogenix.com ELRIG Research and Innovation Meeting March 11th 2014 The right

More information

Introduction to Drug Design and Discovery

Introduction to Drug Design and Discovery Introduction to Drug Design and Discovery Course: Drug Design Course code: 0510412 Dr. Balakumar Chandrasekaran Dr. Bilal Al-Jaidi Assistant Professors, Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy,

More information

Part I. Progress toward the Total Synthesis of Tubulysin Analogs

Part I. Progress toward the Total Synthesis of Tubulysin Analogs Part I. Progress toward the Total Synthesis of Tubulysin Analogs Zhiyong Wang Research Topic Presentation September 16, 2006 Ac S Ph C Four Stage of a Cell Cycle G1-S-G2-M A General Look at the Cell Cycle

More information

Computational methods in drug discovery

Computational methods in drug discovery Computational methods in drug discovery COURSE HIGHLIGHTS v Structure-based drug discovery Ø Binding site identification Ø Molecular docking v Biologics Ø Molecular modelling Ø Protein-Protein docking

More information

Current Research. Examples of current research projects:

Current Research. Examples of current research projects: Current Research Dr Richard Foster Medicinal Chemistry and Chemical Biology Group Leader Medicinal Chemistry Tutor School of Chemistry University of Leeds r.foster@leeds.ac.uk +44 (0)1133435759 Our group

More information

Antibody Discovery at Evotec

Antibody Discovery at Evotec Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic

More information

Small-Molecule Drug Target Identification/Deconvolution Technologies

Small-Molecule Drug Target Identification/Deconvolution Technologies Small-Molecule Drug Target Identification/Deconvolution Technologies Case-Studies Shantani Target ID Technology Tool Box Target Deconvolution is not Trivial = A single Tool / Technology May Not necessarily

More information

Drug Discovery and Development at NIH for Rare and Neglected Diseases September 29, 2009

Drug Discovery and Development at NIH for Rare and Neglected Diseases September 29, 2009 Drug Discovery and Development at NIH for Rare and Neglected Diseases September 29, 2009 Melissa Ashlock, Christopher P. Austin, Steve Groft Genetic Alliance Posted in the Resource Repository at: http://www.resourcerepository.org/documents/1692/drugdiscoveryanddevelopmentat

More information

How Targets Are Chosen. Chris Wayman 12 th April 2012

How Targets Are Chosen. Chris Wayman 12 th April 2012 How Targets Are Chosen Chris Wayman 12 th April 2012 A few questions How many ideas does it take to make a medicine? 10 20 20-50 50-100 A few questions How long does it take to bring a product from bench

More information

NANYANG TECHNOLOGICAL UNIVERSITY SEMESTER I EXAMINATION CBC922 Medicinal Chemistry. NOVEMBER TIME ALLOWED: 120 min

NANYANG TECHNOLOGICAL UNIVERSITY SEMESTER I EXAMINATION CBC922 Medicinal Chemistry. NOVEMBER TIME ALLOWED: 120 min AYAG TECLGICAL UIVERSITY SEMESTER I EXAMIATI 2006-2007 CBC922 Medicinal Chemistry VEMBER 2006 - TIME ALLWED 120 min ISTRUCTIS T CADIDATES 1. This examination paper contains TW (2) parts and comprises SIX

More information

Marine Genetic Resources: Experiences in Commercialization. Background

Marine Genetic Resources: Experiences in Commercialization. Background Marine Genetic Resources: Experiences in Commercialization Marc Slattery University of Mississippi, and ational Institute for Undersea Science & Technology cean Biotechnology Center & Repository United

More information

Includes 'study abroad' Description This lecture module will introduce the following topics: Assessment Assessment Type Exam 1 (100%) Convenor

Includes 'study abroad' Description This lecture module will introduce the following topics: Assessment Assessment Type Exam 1 (100%) Convenor Biomedical Sciences This edition of the University of Nottingham Catalogue of Modules went to press on 7th September 2011. It was derived from information held on the database. The Catalogue is also published

More information

Discovery and Development of Highly Selective and Orally Bioavailable Macrocyclic IDO-1 Inhibitors

Discovery and Development of Highly Selective and Orally Bioavailable Macrocyclic IDO-1 Inhibitors Discovery and Development of Highly Selective and Orally Bioavailable Macrocyclic IDO-1 Inhibitors 1 Tim Briggs Senior Director, Medicinal Chemistry Ensemble Therapeutics Corp. Ensemble Therapeutics Corp.

More information

GE Healthcare Life Sciences. A year of interaction with Biacore X100

GE Healthcare Life Sciences. A year of interaction with Biacore X100 GE Healthcare Life Sciences A year of interaction with Biacore X1 Protein interaction research Real-time monitoring of binding events using surface plasmon resonance (SPR) gives a deep understanding of

More information

Potencial de los productos naturales marinos como agentes anticáncer: La situación de Panamá

Potencial de los productos naturales marinos como agentes anticáncer: La situación de Panamá RIBECACER Potencial de los productos naturales marinos como agentes anticáncer: La situación de Panamá VIII Simposio Iberoamericano de plantas medicinales y III Simposio Iberoamericano de investigación

More information

Chemical Biology In-class discussion: Tethering

Chemical Biology In-class discussion: Tethering In-class discussion: Tethering This discussion will focus on various Tethering Methods described by workers at Sunesis (for a review, see Erlanson et al. Ann. Rev. Biophys. Biomol. Str. 2004). Regarding

More information

Pharmacophore modeling, virtual computational screening and biological evaluation studies

Pharmacophore modeling, virtual computational screening and biological evaluation studies Pharmacophore modeling, virtual computational screening and biological evaluation studies Drug discovery process plays an important role in identifying new investigational drug-likes and developing new

More information

Compound Re-Profiling. Dr Robert Scoffin CEO, Cresset

Compound Re-Profiling. Dr Robert Scoffin CEO, Cresset Compound Re-Profiling Dr Robert Scoffin CEO, Cresset What is it? F F F N N H 2 N S O O Br > Compound Re-Profiling or Re-Purposing is the process of finding a new clinical use for an existing treatment

More information

6th Form Open Day 15th July 2015

6th Form Open Day 15th July 2015 6th Form Open Day 15 th July 2015 DNA is like a computer program but far, far more advanced than any software ever created. Bill Gates Welcome to the Open Day event at the Institute of Genetic Medicine

More information

Impact of Collaborative Robots at The Genomics Institute of the Novartis Research Foundation (GNF) Dan Sipes Novartis Foundation

Impact of Collaborative Robots at The Genomics Institute of the Novartis Research Foundation (GNF) Dan Sipes Novartis Foundation Impact of Collaborative Robots at The Genomics Institute of the Novartis Research Foundation (GNF) Dan Sipes Novartis Foundation Outline What is GNF? Approach How it works The need for collaborative robots

More information

Madagascar periwinkle (Catharanthus roseus) Salix - willow. Biodiversity: Use it or lose it. Biodiversity: Use it or lose it

Madagascar periwinkle (Catharanthus roseus) Salix - willow. Biodiversity: Use it or lose it. Biodiversity: Use it or lose it Applying basic ecological science to make a difference Human Impact on Earth s Ecosystems ~50% of land surface and accessible fresh water used by humans C increase is leading to climate change H H H H

More information

Section 10. Junaid Malek, M.D.

Section 10. Junaid Malek, M.D. Section 10 Junaid Malek, M.D. Cell Division Make sure you understand: How do cells know when to divide? (What drives the cell cycle? Why is it important to regulate this?) How is DNA replication regulated?

More information

Innovative Strategies to Accelerate Academic Drug Discovery. Vincent Groppi, Ph.D Director Center for the Discovery of New Medicines

Innovative Strategies to Accelerate Academic Drug Discovery. Vincent Groppi, Ph.D Director Center for the Discovery of New Medicines Innovative Strategies to Accelerate Academic Drug Discovery Vincent Groppi, Ph.D Director Center for the Discovery of New Medicines 9 out of 10 Drugs Fail Hay, Thomas, Craighead, Economides & Rosenthal.

More information

Competing & Collaborating to Achieve Successful Drug Repositioning

Competing & Collaborating to Achieve Successful Drug Repositioning Competing & Collaborating to Achieve Successful Drug Repositioning Noel Southall, Ph.D. National Human Genome Research Institute National Institutes of Health July 14, 2011 NIH Chemical Genomics Center

More information

CONTRACTING ORGANIZATION: Dana Farber Cancer Institute Boston, MA 02115

CONTRACTING ORGANIZATION: Dana Farber Cancer Institute Boston, MA 02115 AWARD NUMBER: W81XWH-13-1-0212 TITLE: Targeting TMPRSS2-ERG in Prostate Cancer PRINCIPAL INVESTIGATOR: David Takeda CONTRACTING ORGANIZATION: Dana Farber Cancer Institute Boston, MA 02115 REPORT DATE:

More information

Tanja Krainz Current Literature July 9 th, 2016

Tanja Krainz Current Literature July 9 th, 2016 Discovery and Characterization of BMN673 (Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1,2 Inhibitor, as an Anticancer Agent Wang, B.; Chu, D.; Feng, Y.; Shen,

More information

Using Computational Chemistry to Identify New Uses for Old Medicines

Using Computational Chemistry to Identify New Uses for Old Medicines Using Computational Chemistry to Identify New Uses for Old Medicines http://www.re-pharm.com alan@re-pharm.com Re-Pharm summary > Clinical-stage company actively building a drug development pipeline >

More information

Overview and Status Update

Overview and Status Update T H E S C R I P P S R E S E A R C H I N S T I T U T E S C R I P P S F L O R I D A T H E S C R I P P S R E S E A R C H I N S T I T U T E Scripps Florida Overview and Status Update 7 November 2011 Harry

More information

Generation of research tools to translate genomic discoveries into drug discovery projects. Nils Ostermann, Novartis

Generation of research tools to translate genomic discoveries into drug discovery projects. Nils Ostermann, Novartis Generation of research tools to translate genomic discoveries into drug discovery projects Nils Ostermann, Novartis Need for public-private collaboration Common interest Genomic information is growing

More information

BIO8041 BIO3030. Antimicrobial Drug Discovery

BIO8041 BIO3030. Antimicrobial Drug Discovery BIO8041 BIO3030 Antimicrobial Drug Discovery Module overview Intended Knowledge Outcomes The aim of this module is to demonstrate various routes to the discovery of microbial products with commercial value.

More information

OTC-BB STOCK SYMBOL: ENZB EXECUTIVE SUMMARY

OTC-BB STOCK SYMBOL: ENZB EXECUTIVE SUMMARY OTC-BB STOCK SYMBOL: ENZB EXECUTIVE SUMMARY EnzymeBioSystems ( ENZB ), a Nevada corporation, was founded on June 26, 2009, for the purpose of utilizing enzyme technologies to develop commercial solutions

More information

North Carolina Research Campus Kannapolis, NC

North Carolina Research Campus Kannapolis, NC North Carolina Research Campus Kannapolis, NC Why me? Came from Kannapolis area to UNC in 1966 Began working in RTP in 1971 (RTP had begun in the late 50s) Part of the reason for RTP was to keep people

More information

20S Proteasome Assay Kit

20S Proteasome Assay Kit 20S Proteasome Assay Kit Item No. 10008041 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd Ann Arbor, MI USA TABLE OF CONTENTS GENERAL INFORMATION 3

More information

Application of Deep Learning to Drug Discovery

Application of Deep Learning to Drug Discovery Application of Deep Learning to Drug Discovery Hase T, Tsuji S, Shimokawa K, Tanaka H Tohoku Medical Megabank Organization, Tohoku University Current Situation of Drug Discovery Rapid increase of R&D expenditure

More information

COURSES IN BIOLOGICAL SCIENCE. Undergraduate Courses Postgraduate Courses

COURSES IN BIOLOGICAL SCIENCE. Undergraduate Courses Postgraduate Courses COURSES IN BIOLOGICAL SCIENCE Undergraduate Courses Postgraduate Courses Undergraduate Courses: BISC 001 Appreciation of Biological Sciences [3-0-0:3] Diversity of life forms; origin of life; chemical

More information

Marineinspired Oncology

Marineinspired Oncology Marineinspired Oncology Nature distributed medicine everywhere. Pliny the Elder. 74 AD 2 3 Leaders in marine biotecnology Group structure Oncology Company Other business PharmaMar is a global biopharmaceutical

More information

MANIFESTO OF STUDIES 2013

MANIFESTO OF STUDIES 2013 MANIFESTO OF STUDIES 2013 1st YEAR - MANDATORY COURSES - Course Teacher Hours Synopsis Evaluation procedure Laboratory Safety Course (Mandatory) Prof. Mancini I. Dr. Provenzani A. 12 General Laboratory

More information

= -1-EUROPEAN CD3. "Stimulating innovation in drug discovery" 21 May 2010 Innovation in Healthcare. Centre for Drug Design and Discovery

= -1-EUROPEAN CD3. Stimulating innovation in drug discovery 21 May 2010 Innovation in Healthcare. Centre for Drug Design and Discovery Centre for Drug Design and Discovery CD3 Centre for Drug Design and Discovery "Stimulating innovation in drug discovery" 21 May 2010 Innovation in Healthcare = -1-EUROPEAN FUND PROVINOE \/laams 8RABANT

More information

Polypharmacology. Giulio Rastelli Molecular Modelling and Drug Design Lab

Polypharmacology. Giulio Rastelli Molecular Modelling and Drug Design Lab Polypharmacology Giulio Rastelli Molecular Modelling and Drug Design Lab www.mmddlab.unimore.it Dipartimento di Scienze della Vita Università di Modena e Reggio Emilia giulio.rastelli@unimore.it Magic

More information

Concept of Integrated Research Platforms

Concept of Integrated Research Platforms Concept of Integrated Research Platforms Michal Vlasin UVPS Brno, Czech Republic Lumir Krejci October 21, 2010 INTEGRATED RESEARCH PLATFORMS AC: Animal Center CBCE: Center of Biomolecular and Cellular

More information

Medicinal Chemistry of Modern Antibiotics

Medicinal Chemistry of Modern Antibiotics Chemistry 259 Medicinal Chemistry of Modern Antibiotics Spring 2012 Lecture 5: Modern Target Discovery & MOA Thomas Hermann Department of Chemistry & Biochemistry University of California, San Diego Drug

More information

Medicinal Chemistry of Modern Antibiotics

Medicinal Chemistry of Modern Antibiotics Chemistry 259 Medicinal Chemistry of Modern Antibiotics Spring 2008 Lecture 5: Modern Target Discovery & MOA Thomas Hermann Department of Chemistry & Biochemistry University of California, San Diego Drug

More information

DNA REPLICATION & BIOTECHNOLOGY Biology Study Review

DNA REPLICATION & BIOTECHNOLOGY Biology Study Review DNA REPLICATION & BIOTECHNOLOGY Biology Study Review DNA DNA is found in, in the nucleus. It controls cellular activity by regulating the production of, which includes It is a very long molecule made up

More information

Advanced Therapeutic Antibody Discovery with Multiplexed Screening

Advanced Therapeutic Antibody Discovery with Multiplexed Screening Advanced Therapeutic Antibody Discovery with Multiplexed Screening White Paper Scientists need powerful tools that can deliver results to fully understand the ability of candidate antibodies to interrupt

More information

Chemical Peptide Synthesis in the Development of Protein Therapeutics

Chemical Peptide Synthesis in the Development of Protein Therapeutics Chemical Peptide Synthesis in the Development of Protein Therapeutics Stephen Kent Abstract Effective automated SPPS is key to the synthesis of peptide building blocks for chemical protein synthesis, and

More information

Application of Deep Learning to Drug Discovery

Application of Deep Learning to Drug Discovery Application of Deep Learning to Drug Discovery Hiroshi Tanaka Tohoku Medical Megabank Orga nization, Tohoku University Current Situation of Drug Discovery Rapid increase of R&D expenditure More than 1B

More information

Targeting the Functional Activity of PrP C as a Novel Strategy for Drug Discovery in Prion Diseases

Targeting the Functional Activity of PrP C as a Novel Strategy for Drug Discovery in Prion Diseases Targeting the Functional Activity of PrP C as a Novel Strategy for Drug Discovery in Prion Diseases Emiliano Biasini Department of Biochemistry Boston University School of Medicine One protein, two forms:

More information

March 8 [FRI], :00-17:00. - Program -

March 8 [FRI], :00-17:00. - Program - International Joint Seminar between School of Pharmaceutical Sciences, Peking University, & School of Pharmacy/Pharmaceutical Sciences, Kanazawa University in Kanazawa March 8 [FRI], 2013. 14:00-17:00

More information

Targeted Protein Degradation Therapeutics

Targeted Protein Degradation Therapeutics Targeted Protein Degradation Therapeutics Hijacking Ubiquitin E3 Ligases Using PROTAC Technology to Effectively Degrade BRD4 and Achieve Anti- tumor Efficacy Yimin Qian; Kanak Raina; Jing Lu; Martha Altieri;

More information

The main goal of the strategic partnership is the development of innovative, all-natural cosmetic active ingredients and aroma molecules.

The main goal of the strategic partnership is the development of innovative, all-natural cosmetic active ingredients and aroma molecules. PRESS RELEASE Symrise: Strategic partnership with BRAIN and AnalytiCon Discovery (Holzminden/Potsdam/Zwingenberg, April 2, 2007) Symrise GmbH & Co. KG, the world s fourth-largest supplier of fragrance

More information

Time allowed: 2 hours Answer ALL questions in Section A, ALL PARTS of the question in Section B and ONE question from Section C.

Time allowed: 2 hours Answer ALL questions in Section A, ALL PARTS of the question in Section B and ONE question from Section C. UNIVERSITY OF EAST ANGLIA School of Biological Sciences Main Series UG Examination 2017-18 CELL BIOLOGY BIO-5005B Time allowed: 2 hours Answer ALL questions in Section A, ALL PARTS of the question in Section

More information

SUPPLEMENTARY INFORMATION Figures. Supplementary Figure 1 a. Page 1 of 30. Nature Chemical Biology: doi: /nchembio.2528

SUPPLEMENTARY INFORMATION Figures. Supplementary Figure 1 a. Page 1 of 30. Nature Chemical Biology: doi: /nchembio.2528 SUPPLEMENTARY INFORMATION Figures Supplementary Figure 1 a b c Page 1 of 0 11 Supplementary Figure 1: Biochemical characterisation and binding validation of the reversible USP inhibitor 1. a, Biochemical

More information

leading the way in research & development

leading the way in research & development leading the way in research & development people. passion. possibilities. ABBVIE 2 immunology AbbVie Immunology has a demonstrated record of success in identifying and developing both small molecule and

More information

Time-resolved interaction analysis on living cells: Comprehensive data generates new knowledge and better decisions

Time-resolved interaction analysis on living cells: Comprehensive data generates new knowledge and better decisions Time-resolved interaction analysis on living cells: Comprehensive data generates new knowledge and better decisions Karl Andersson CEO karl@ridgeview.eu Karl Andersson, PhD Ridgeview Instruments AB Molecular

More information

The ChEMBL Database. ICIC 2012 Berlin, Germany October John P. Overington EMBL- EBI.

The ChEMBL Database. ICIC 2012 Berlin, Germany October John P. Overington EMBL- EBI. The ChEMBL Database ICIC 2012 Berlin, Germany October 2012 John P. Overington EMBL- EBI jpo@ebi.ac.uk Chemical Space All compounds Drug-like compounds Available compounds Only certain molecules have features

More information

Dennis Wright, Ph.D. Professor of Medicinal Chemistry NPDD Initiative UCONN School of Pharmacy University of Connecticut

Dennis Wright, Ph.D. Professor of Medicinal Chemistry NPDD Initiative UCONN School of Pharmacy University of Connecticut Craig M. Crews, Ph.D. Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology Chemistry, Pharmacology Center for Molecular Discovery Yale University Dennis Wright, Ph.D. Professor

More information

Development and Utilization of Bromodomain and Extra Terminal Domain (BET) Assays Using AlphaLISA Technology

Development and Utilization of Bromodomain and Extra Terminal Domain (BET) Assays Using AlphaLISA Technology APPLICATION NOTE AlphaLISA Technology Authors: Hong Cao Daniel Cardillo Jen Carlstrom Dawn Nida PerkinElmer, Inc. Hopkinton, MA Development and Utilization of Bromodomain and Extra Terminal Domain (BET)

More information

Introducing the Department of Life Sciences

Introducing the Department of Life Sciences Introducing the Department of Life Sciences Life Sciences is a discipline that aims at a fundamental understanding of life phenomena by exploring complex and mysterious structures and funct ions of living

More information

The Kinase Knowledgebase

The Kinase Knowledgebase The Kinase Knowledgebase Kevin P. Hambly Product Manager Derek A. Debe, Ph.D. Chief Scientific Officer Outline About Eidogen-Sertanty Kinase Knowledgebase Overview Content Curation Process Data Structure

More information

Fig. 1. A schematic illustration of pipeline from gene to drug : integration of virtual and real experiments.

Fig. 1. A schematic illustration of pipeline from gene to drug : integration of virtual and real experiments. 1 Integration of Structure-Based Drug Design and SPR Biosensor Technology in Discovery of New Lead Compounds Alexis S. Ivanov Institute of Biomedical Chemistry RAMS, 10, Pogodinskaya str., Moscow, 119121,

More information

Centre for Synthetic Biology

Centre for Synthetic Biology Centre for Synthetic Biology Preface Introduction The Groningen Centre for Synthetic Biology (CSB) was established to foster research expertise in the emerging field of synthetic biology. It incorporates

More information

Products & Services. Customers. Example Customers & Collaborators

Products & Services. Customers. Example Customers & Collaborators Products & Services Eidogen-Sertanty is dedicated to delivering discovery informatics technologies that bridge the target-tolead knowledge gap. With a unique set of ligand- and structure-based drug discovery

More information

TITLE: Prostate Specific Antigen-Triggered Prodrug of S-Trityl-L-Cysteine, an Eg5 Kinesin Inhibitor and Antimitosis Agent with Low Neurotoxicity

TITLE: Prostate Specific Antigen-Triggered Prodrug of S-Trityl-L-Cysteine, an Eg5 Kinesin Inhibitor and Antimitosis Agent with Low Neurotoxicity AD Award Number: W81XWH-07-1-0118 TITLE: Prostate Specific Antigen-Triggered Prodrug of S-Trityl-L-Cysteine, an Eg5 Kinesin Inhibitor and Antimitosis Agent with Low Neurotoxicity PRINCIPAL INVESTIGATOR:

More information

Course Handbook MSc in Bioengineering Tissue Engineering Specialisation

Course Handbook MSc in Bioengineering Tissue Engineering Specialisation Course Handbook 2013-2014 MSc in Bioengineering Tissue Engineering Specialisation 1 Course Objectives & Learning Outcomes This programme aims to give a sound and broad basis in tissue engineering. In particular,

More information

Practical Workshop: Chemical Biology, Drug Discovery and Screening

Practical Workshop: Chemical Biology, Drug Discovery and Screening Practical Workshop: Chemical Biology, Drug Discovery and Screening Date: 23-25 October 2013 Location: European ScreeningPort GmbH, Schnackenburgallee 114, 22525 Hamburg, Germany Course overview The emergence

More information

Sabrina Jedlicka 9/24/2012. NEUROENGINEERING: Interactions of Neurons and Materials

Sabrina Jedlicka 9/24/2012. NEUROENGINEERING: Interactions of Neurons and Materials Sabrina Jedlicka 9/24/2012 NEUROENGINEERING: Interactions of Neurons and Materials What is neuroengineering? Neuroengineering combines engineering and computational approaches to problems in basic and

More information